170 related articles for article (PubMed ID: 9810661)
1. In-vitro activity of three fluoroquinolones, cefotaxime and clindamycin against staphylococci.
Schumacher-Perdreau F; Peters G
Zentralbl Bakteriol; 1995 Oct; 282(4):389-93. PubMed ID: 9810661
[TBL] [Abstract][Full Text] [Related]
2. Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin.
Barry AL; Fuchs PC
J Antimicrob Chemother; 1991 Nov; 28(5):695-9. PubMed ID: 1663929
[TBL] [Abstract][Full Text] [Related]
3. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
Wallrauch C; Voss A; Milatovic D; Braveny I
Arzneimittelforschung; 1995 Jun; 45(6):723-5. PubMed ID: 7646580
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.
Rotstein C; Amsterdam D; Beam TR; Mandell LA; Gorzynski EA
Diagn Microbiol Infect Dis; 1993 Jul; 17(1):85-91. PubMed ID: 8395375
[TBL] [Abstract][Full Text] [Related]
5. Activity of new quinolones against ciprofloxacin-resistant staphylococci.
Forstall GJ; Knapp CC; Washington JA
Antimicrob Agents Chemother; 1991 Aug; 35(8):1679-81. PubMed ID: 1656873
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of action of quinolones against staphylococci and relationship with their in vitro bactericidal activity.
Ramón MS; Cantón E; Pemán J; Pastor A; Martínez JP
Chemotherapy; 1999; 45(3):175-82. PubMed ID: 10224339
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of temafloxacin against gram-positive cocci including methicillin-resistant Staphylococcus aureus.
Fuchs PC
Am J Med; 1991 Dec; 91(6A):15S-18S. PubMed ID: 1662886
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Smith KR; Cobbs CG
Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):55-8. PubMed ID: 1314175
[TBL] [Abstract][Full Text] [Related]
9. The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae.
George J; Morrissey I
J Antimicrob Chemother; 1997 Jun; 39(6):719-23. PubMed ID: 9222040
[TBL] [Abstract][Full Text] [Related]
10. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
McCarter YS; Mazens-Sullivan MF; Bartlett RC
Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
[TBL] [Abstract][Full Text] [Related]
11. In vitro activity of levofloxacin against coagulase-positive and -negative staphylococci.
Cafiso V; Messina C; Santagati M; Campanile F; Bonfiglio G; Stefani S
Drugs Exp Clin Res; 2001; 27(3):107-11. PubMed ID: 11447768
[TBL] [Abstract][Full Text] [Related]
12. Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin.
Barry AL; Fuchs PC
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):168-71. PubMed ID: 2060518
[TBL] [Abstract][Full Text] [Related]
13. A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
Amyes SG; Baird DR; Crook DW; Gillespie SH; Howard AJ; Oppenhiem BA; Pedler SJ; Paull A; Tompkins DS; Lawrie SA
J Antimicrob Chemother; 1994 Nov; 34(5):639-48. PubMed ID: 7706159
[TBL] [Abstract][Full Text] [Related]
14. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
Chin NX; Figueredo VM; Novelli A; Neu HC
Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):58-63. PubMed ID: 3132380
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone.
Yamakawa T; Mitsuyama J; Hayashi K
J Antimicrob Chemother; 2002 Mar; 49(3):455-65. PubMed ID: 11864945
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolone susceptibilities to methicillin-resistant and susceptible coagulase-negative Staphylococcus isolated from eye infection.
Oliveira AD; Höfling-Lima AL; Belfort R; Gayoso Mde F; Francisco W
Arq Bras Oftalmol; 2007; 70(2):286-9. PubMed ID: 17589701
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
Ko WC; Chiang SR; Lee HC; Tang HJ; Wang YY; Chuang YC
Antimicrob Agents Chemother; 2003 Jul; 47(7):2217-22. PubMed ID: 12821471
[TBL] [Abstract][Full Text] [Related]
19. In-vitro activity of new sulphanilil fluoroquinolones against Staphylococcus aureus.
Allemandi DA; Alovero FL; Manzo RH
J Antimicrob Chemother; 1994 Aug; 34(2):261-5. PubMed ID: 7814287
[TBL] [Abstract][Full Text] [Related]
20. Dissociated resistance among fluoroquinolones.
Thomson KS; Sanders CC
Antimicrob Agents Chemother; 1994 Sep; 38(9):2095-100. PubMed ID: 7811025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
